论文部分内容阅读
癌性体腔积液是晚期恶性肿瘤患者常见的并发症,自1998年1月以来,我们应用山东鲁抗医药集团鲁亚有限公司生产的抗肿瘤免疫赋活剂沙培林(链球菌722制剂)治疗恶性体腔积液30例,现分析如下。1 材料与方法11 研究对象30例患者均为经病理或细胞学证实的恶性肿瘤患者,其中心包积液2
Cancerous body fluid effusion is a common complication in patients with advanced malignant tumors. Since January 1998, we have applied Sha Pelin (Streptococcus 722), an anti-tumor immunostimulant produced by Shandong Lukang Pharmaceutical Group Luya Co., Ltd. Treatment of malignant body cavity fluid in 30 cases, are analyzed as follows. 1 Materials and Methods 11 Research subjects 30 patients were pathological or cytologically confirmed malignant tumor patients, the center of effusion 2